Transcription factors LSF and E2Fs Tandem cyclists driving G0 to S?

被引:32
作者
Hansen, Ulla [1 ,2 ]
Owens, Laura [2 ]
Saxena, Utsav H. [1 ]
机构
[1] Boston Univ, Dept Biol, Boston, MA 02215 USA
[2] Boston Univ, Program Mol Biol, Boston, MA 02215 USA
关键词
LSF; cyclin C/CDK; ERK; thymidylate synthetase; E2F; pRb; p53; G(1) phase; S phase; restriction point; AMYLOID PRECURSOR PROTEIN; MITOGENIC STIMULATION; DNA-BINDING; FACTOR CP2; FAMILY; EXPRESSION; TARGET; GENE; PHASE; ROLES;
D O I
10.4161/cc.8.14.9089
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Cell cycle progression in mammalian cells from G(1) into S phase requires sensing and integration of multiple inputs, in order to determine whether to continue to cellular DNA replication and subsequently, to cell division. Passage to S requires transition through the restriction point, which at a molecular level consists of a bistable switch involving E2Fs and pRb family members. At the G(1)/S boundary, a number of genes essential for DNA replication and cell cycle progression are upregulated, promoting entry into S phase. Although the activating E2Fs are the most extensively characterized transcription factors driving G(1)/S expression, LSF is also a transcription factor essential for stimulating G(1)/S gene expression. A critical LSF target gene at this stage, Tyms, encodes thymidylate synthetase. In investigating how LSF is activated in a cell cycle-dependent manner, we recently identified a novel time delay mechanism for regulating its activity during G1 progression, which is apparently independent of the E2F/pRb axis. This involves inhibition of LSF in early G(1) by two major proliferative signaling pathways: ERK and cyclin C/CDK, followed by gradual dephosphorylation during mid-to late-G(1). Whether LSF and E2F act independently or in concert to promote G(1)/S progression remains to be determined.
引用
收藏
页码:2146 / 2151
页数:6
相关论文
共 45 条
[1]
Hitting their targets: an emerging picture of E2F and cell cycle control [J].
Blais, A ;
Dynlacht, BD .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2004, 14 (05) :527-532
[2]
E2F target genes: unraveling the biology [J].
Bracken, AP ;
Ciro, M ;
Cocito, A ;
Helin, K .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (08) :409-417
[3]
Fe65, a ligand of the Alzheimer's β-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression [J].
Bruni, P ;
Minopoli, G ;
Branccaccio, T ;
Napolitano, M ;
Faraonio, R ;
Zambrano, N ;
Hansen, U ;
Russo, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) :35481-35488
[4]
Emerging roles for E2F: Beyond the G1/S transition and DNA replication [J].
Cam, H ;
Dynlacht, BD .
CANCER CELL, 2003, 3 (04) :311-316
[5]
The relative cellular levels of CP2a and CP2b potentiates erythroid cell-specific expression of the α-globin gene by regulating the nuclear localization of CP2c [J].
Chae, Ji Hyung ;
Kang, Ho Chul ;
Kim, Chul Geun .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 380 (04) :813-817
[6]
Pocket proteins and cell cycle control [J].
Cobrinik, D .
ONCOGENE, 2005, 24 (17) :2796-2809
[7]
Cell Cycle Genes Are the Evolutionarily Conserved Targets of the E2F4 Transcription Factor [J].
Conboy, Caitlin M. ;
Spyrou, Christiana ;
Thorne, Natalie P. ;
Wade, Elizabeth J. ;
Barbosa-Morais, Nuno L. ;
Wilson, Michael D. ;
Bhattacharjee, Arindam ;
Young, Richard A. ;
Tavare, Simon ;
Lees, Jacqueline A. ;
Odom, Duncan T. .
PLOS ONE, 2007, 2 (10)
[8]
THYMIDYLATE SYNTHETASE - TARGET ENZYME IN CANCER CHEMOTHERAPY [J].
DANENBERG, PV .
BIOCHIMICA ET BIOPHYSICA ACTA, 1977, 473 (02) :73-92
[9]
The genetics of the E2F family of transcription factors: shared functions and unique roles [J].
DeGregori, J .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2002, 1602 (02) :131-150
[10]
The E2F transcriptional network: old acquaintances with new faces [J].
Dimova, DK ;
Dyson, NJ .
ONCOGENE, 2005, 24 (17) :2810-2826